Except for ICU patients, ceftolozane-tazobactam is a treatment option for multi-drug resistant P. aeruginosa.

Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.

  • Jorgensen SCJ. et al
  • Rédigé par : Dr Olivier Leroy
Gram-negative bacilli and especially P. aeruginosa are responsible for increasingly multi-drug resistance challenging problems. The association between a new cephalosporin and a well-established beta-lactamase inhibitor could be interesting in these cases. Although in France, labeled indications for ceftolozane-tazobactam (C/T) are limited to infections due to P. aeruginosa resistant to other b...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.

Déjà inscrit / Already registered ?

Créer un compte / Create an account

Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.